You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Reactivity
Predicted Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'IGF'
RecombinantIGF-II,Human [orb1494836]> 95% as analyzed by SDS-PAGE and HPLC.
7.6 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
50 μg, 10 μg, 1 mg- RecombinantIGF-I,Rat [orb1494837]
> 95% as analyzed by SDS-PAGE and HPLC.
7.8 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg - RecombinantIGF-I,Mouse [orb1494838]
> 95% by SDS-PAGE analysis.
7.8 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg - RecombinantIGF-I,Human [orb1494839]
> 95% by SDS-PAGE and HPLC analyses.
7.7 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg - RecombinantIGF-I(N-Met),Human [orb1494840]
> 95% as analyzed by SDS-PAGE.
7.8 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg - RecombinantIGF-BP-4,His,Human [orb1494644]
> 95% as analyzed by SDS-PAGE.
30-35 kDa, observed by reducing SDS-PAGE.
HEK 293
50 μg, 10 μg, 1 mg - RecombinantIGF-BP-2,His,Human [orb1494645]
> 95% as analyzed by SDS-PAGE.
6-20 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg, 1 mg - Recombinant Human IGF-BP3 ( rHuIGF-BP3 ) [orb1494967]
>98% by SDS-PAGE and HPLC analyses.
28.8 kDa protein consisting of 264 amino acid residues..
Escherichia coli.
1 mg, 5 μg, 25 μg >95% by SDS-PAGE and HPLC analyses.
Approximately 9.1 kDa, a single non-glycosylated polypeptide chain containing 83 amino acids.
Escherichia coli.
1 mg, 100 μg, 20 μg>85% by SDS-PAGE and HPLC analyses.
Approximately 9.1 kDa, a single non-glycosylated polypeptide chain containing 83 amino acids.
Escherichia coli.
1 mg